Tilray Disappoints Investors With Losses and Falling Stock Despite Cannabis Sales Growth

Tilray reported disappointing sales and losses, causing its stock and other marijuana stocks to fall significantly
Tilray had decent growth in cannabis sales but much was from an acquisition rather than organic growth
Despite cost-cutting, Tilray admitted it won't reach positive free cash flow this year as previously stated
Even the largest marijuana companies are struggling to make profits in the current business environment
Analysts don't expect most major cannabis companies to reach positive cash flow for years, if ever